制备方法

1.取新鲜或冷冻的鸡(或鸭、鹅)胆汁,加入1/10量的工业氢氧化钠,加热煮沸20～24h,并不断补充蒸发的水量,冷却,再用盐酸调pH值为2～3,出现黑色膏状物。静置分层后,取出膏状物,水洗至中性,得总胆汁酸。总胆汁酸中加入2倍量95%乙醇和10%活性炭,加热回流2～3h,趁热过滤。滤液冷却,再加入等体积120号汽油萃取3次脱脂,静置分层,分出下层液体进行减压浓缩,得膏状物。加入大量水到膏状物中,析出沉淀,用水将沉淀洗涤至无色。然后向沉淀物中加入2倍量95%乙醇及5%的氢氧化钠溶液,调节pH=8.5,加热回流2h。再按每升150g的量加入氯化钡,加热回流2h,趁热过滤,滤液浓缩至呈现晶膜或浑浊时,放冷,析出晶体,抽滤,水洗,减压干燥,可得白色鹅去氧胆酸钡盐结晶。再将钡盐用水溶解,并加入含钡盐12%左右的碳酸钠,加热搅拌,过滤,弃去碳酸钡沉淀,滤液再用盐酸调pH=2～3,析出沉淀,过滤,滤饼水洗至中性,干燥,可得鹅去氧胆酸成品。必要时可再用乙酸乙酯重结晶1～2次。 也有采用氯化钙盐提取的方法。

合成制备方法

1.取新鲜或冷冻的鸡（或鸭、鹅）胆汁，加入1/10量的工业氢氧化钠，加热煮沸20～24h，并不断补充蒸发的水量，冷却，再用盐酸调pH值为2～3，出现黑色膏状物。静置分层后，取出膏状物，水洗至中性，得总胆汁酸。总胆汁酸中加入2倍量95%乙醇和10%活性炭，加热回流2～3h，趁热过滤。滤液冷却，再加入等体积120号汽油萃取3次脱脂，静置分层，分出下层液体进行减压浓缩，得膏状物。加入大量水到膏状物中，析出沉淀，用水将沉淀洗涤至无色。然后向沉淀物中加入2倍量95%乙醇及5%的氢氧化钠溶液，调节pH=8.5，加热回流2h。再按每升150g的量加入氯化钡，加热回流2h，趁热过滤，滤液浓缩至呈现晶膜或浑浊时，放冷，析出晶体，抽滤，水洗，减压干燥，可得白色鹅去氧胆酸钡盐结晶。再将钡盐用水溶解，并加入含钡盐12%左右的碳酸钠，加热搅拌，过滤，弃去碳酸钡沉淀，滤液再用盐酸调pH=2～3，析出沉淀，过滤，滤饼水洗至中性，干燥，可得鹅去氧胆酸成品。必要时可再用乙酸乙酯重结晶1～2次。

也有采用氯化钙盐提取的方法。

用途简介

1.可作为溶解胆结石的药物,用于预防和治疗胆固醇性胆结石和高脂血症,对胆色素性结石和混石结石也有一定疗效

用途

1.可作为溶解胆结石的药物，用于预防和治疗胆固醇性胆结石和高脂血症，对胆色素性结石和混石结石也有一定疗效

海关代码：

2918990090

WGK_Germany：

2
德国有关水污染物质的分类清单

危险类别码：

R63

安全说明：

S22-S24/25-S45-S36/37

RTECS号：

FZ1980000

危险标志：

Xn:Harmful

CHEMICAL IDENTIFICATION

RTECS NUMBER :

FZ1980000

CHEMICAL NAME :

5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy-

CAS REGISTRY NUMBER :

474-25-9

LAST UPDATED :

199806

DATA ITEMS CITED :

30

MOLECULAR FORMULA :

C24-H40-O4

MOLECULAR WEIGHT :

392.64

WISWESSER LINE NOTATION :

L E5 B666TJ A1 E1 FY1&2VQ KQ OQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

4 gm/kg

TOXIC EFFECTS :

Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - dyspnea Gastrointestinal - hypermotility, diarrhea

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

105 mg/kg

TOXIC EFFECTS :

Behavioral - somnolence (general depressed activity) Gastrointestinal - other changes Skin and Appendages - hair

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Subcutaneous

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

>4 gm/kg

TOXIC EFFECTS :

Blood - changes in spleen Skin and Appendages - hair

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intravenous

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

106 mg/kg

TOXIC EFFECTS :

Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intramuscular

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

>500 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

>2 gm/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intraperitoneal

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

86 mg/kg

TOXIC EFFECTS :

Behavioral - somnolence (general depressed activity) Gastrointestinal - hypermotility, diarrhea Gastrointestinal - other changes

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Subcutaneous

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

>4 gm/kg

TOXIC EFFECTS :

Gastrointestinal - ulceration or bleeding from small intestine Skin and Appendages - hair

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intravenous

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

100 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Intramuscular

SPECIES OBSERVED :

Rodent - mouse

DOSE/DURATION :

>1 gm/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Mammal - dog

DOSE/DURATION :

>1 gm/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - hamster

DOSE/DURATION :

500 mg/kg

TOXIC EFFECTS :

Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

3750 mg/kg/30D-C

TOXIC EFFECTS :

Endocrine - changes in adrenal weight Related to Chronic Data - changes in prostate weight Related to Chronic Data - changes in testicular weight

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

45500 mg/kg/26W-C

TOXIC EFFECTS :

Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases Related to Chronic Data - death

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Rodent - rat

DOSE/DURATION :

18200 mg/kg/52W-C

TOXIC EFFECTS :

Liver - other changes Liver - changes in liver weight

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

SPECIES OBSERVED :

Human - woman

DOSE/DURATION :

24 gm/kg/5Y-C

TOXIC EFFECTS :

Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

100 mg/kg

SEX/DURATION :

male 1 day(s) pre-mating

TOXIC EFFECTS :

Reproductive - Effects on Embryo or Fetus - fetal death

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1785 mg/kg

SEX/DURATION :

female 4-20 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - hepatobiliary system

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

550 mg/kg

SEX/DURATION :

female 7-17 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Effects on Newborn - physical

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1375 mg/kg

SEX/DURATION :

female 7-17 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - musculoskeletal system

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

3480 mg/kg

SEX/DURATION :

female 15-22 day(s) after conception lactating female 21 day(s) post-birth

TOXIC EFFECTS :

Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

14820 mg/kg

SEX/DURATION :

female 31 week(s) pre-mating female 1-24 week(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - hepatobiliary system

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1500 mg/kg

SEX/DURATION :

female 21-45 day(s) after conception

TOXIC EFFECTS :

Reproductive - Specific Developmental Abnormalities - hepatobiliary system Reproductive - Specific Developmental Abnormalities - endocrine system Reproductive - Specific Developmental Abnormalities - urogenital system

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

1500 mg/kg

SEX/DURATION :

female 21-45 day(s) after conception

TOXIC EFFECTS :

Reproductive - Effects on Newborn - physical

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Oral

DOSE :

260 mg/kg

SEX/DURATION :

female 6-18 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Specific Developmental Abnormalities - musculoskeletal system

MUTATION DATA

TYPE OF TEST :

DNA adduct

TEST SYSTEM :

Mammal - species unspecified Lymphocyte

DOSE/DURATION :

10 mg/L

REFERENCE :

CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 15,1911,1994

毒理学数据：

暂无

生态数据：

该物质对环境可能有危害，对水体应给予特别注意。

中国海关编码：2918990090

概述：

2918990090. 其他含其他附加含氧基羧酸（包括酸酐、酰卤化物、过氧化物和过氧酸及该税号的衍生物）. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

申报要素：

品名, 成分含量, 用途

摘要/Summary：

2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

分子结构数据

1、   摩尔折射率：109.65

2、   摩尔体积（cm³/mol）：347.8

3、   等张比容（90.2K）：905.9

4、   表面张力（dyne/cm）：46.0

5、   极化率（10^-24cm³）：43.46

计算化学数据

1.疏水参数计算参考值（XlogP）:4.9

2.氢键供体数量:3

3.氢键受体数量:4

4.可旋转化学键数量:4

5.互变异构体数量:无

6.拓扑分子极性表面积77.8

7.重原子数量:28

8.表面电荷:0

9.复杂度:605

10.同位素原子数量:0

11.确定原子立构中心数量:10

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

• 
  鹅去氧胆酸红外图谱(IR1)
• 
  鹅去氧胆酸红外图谱(IR2)